Trusted by the world’s leading institutions
Researchers from the University of California, Irvine have found evidence of the molecular causes of the damaging impact heat stress causes on the gut, liver and brain in the elderly. These findings point to the potential of developing precise prognostic and therapeutic interventions.
When low-income entrepreneurs start their own businesses, they frequently fear failure — a well-documented phenomenon. But over time, they may also fear success, given the costs and unknowns it can bring, and this barrier to growth is under-studied and underappreciated. A new study from a Keough School of Global Affairs expert breaks new ground by explaining this fear and offers five recommendations to help entrepreneurs overcome it and move out of poverty.
Brian Schaffner, a political science professor and Newhouse Professor of Civic Studies in the School of Arts and Sciences and the Jonathan M. Tisch College of Civic Life, has been named to the 2024 class of Andrew Carnegie Fellows by Carnegie Corporation of New York.
Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive license agreement with Vanderbilt University for the rights to a xenogeneic cross-circulation platform that restores damaged donor organs to transplant condition.
4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, has been granted Breakthrough Device designation by the U.S.
Sonic Youth co-founder and guitarist Lee Ranaldo is receiving an honorary Doctor of Music from Binghamton University, State University of New York at this year's Commencement.
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.
In a study in ACS Nano, researchers describe swarms of microscale robots (microrobots) that captured bits of plastic and bacteria from water. Afterward, the bots were decontaminated and reused.
NeuroTherapia, an early-stage clinical pharmaceutical company, announced today that it has received a grant from the Alzheimer's Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of Alzheimer's disease (AD).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
